Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Jingsong Wang
Person

Jingsong Wang

Tracked across 2 events · 13 articles · First seen Jun 10, 2026 · Last active Jun 12, 2026

Sentiment
0
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 0
Business
Harbour BioMed HBM7004 IND Accepted by NMPA
Harbour BioMed, a global biopharmaceutical company, announced that the China — National Medical Products Administration (NMPA) of China has accepted its Investigational New Drug (IND) application for HBM7004. HBM7004 is a novel B7H4xCD3 bispecific antibody…
Impact: Jingsong Wang, as the Founder, Chairman, and CEO of Harbour BioMed, expressed satisfaction with the NMPA's acceptance of the IND application for HBM7004, highlighting the company's strategy in developing differentiated immunotherapies.
Jun 10, 2026 · 7 articles
2 0
Business
Harbour_BioMed appoints Dhavalkumar_Patel
Harbour BioMed>>> announced the appointment of Dhavalkumar Patel>>> as a Scientific Advisor. Dhavalkumar Patel>>> brings over two decades of experience in therapeutic innovation from roles at Sana Biotechnology>>>, EITC>>>, and Novartis>>>. His expertise is expected…
Impact: Jingsong Wang>>>, CEO of Harbour BioMed>>>, expressed enthusiasm for Dhavalkumar Patel>>>'s appointment.
Jun 12, 2026 · 6 articles
NEWSDESK
Track Jingsong Wang live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.